| Microorganism |
MIC50
(μg/ml) |
MIC90
(μg/ml) |
Range
(μg/ml) |
Antimicrobial |
Reference |
| Staphylococcus haemolyticus (methicillin-susceptible) |
0.5 |
2 |
25 － 2 |
Cefprozil (Cefzil)  |
1492 |
| Staphylococcus haemolyticus (methicillin-susceptible) |
1 |
2 |
0.25 － 4 |
Cefaclor (Ceclor, Ceclor CD) |
1492 |
| Staphylococcus haemolyticus (methicillin-susceptible) |
1 |
2 |
0.5 － 2 |
Cefuroxime (Kefurox, Zinacef) |
1492 |
| Staphylococcus haemolyticus (methicillin-susceptible) |
1 |
2 |
? － ? |
Vancomycin (Vancocyn, Lyphocin) |
1111 |
| Staphylococcus haemolyticus (methicillin-susceptible) |
2 |
4 |
1 － 4 |
Cefpodoxime |
1492 |
| Staphylococcus haemolyticus (methicillin-susceptible) |
4 |
32 |
? － ? |
Teicoplanin (Targocid) |
1111 |
| Staphylococcus haemolyticus (methicillin-susceptible) |
16 |
32 |
2 － 32 |
Cefixime (Suprax) |
1492 |
| Staphylococcus haemolyticus (methicillin-susceptible) |
64 |
>64 |
8 － >64 |
Ceftibuten (Cedax) |
1492 |
| Staphylococcus haemolyticus (methicillin-susceptible) |
- |
0.13 |
≤0.03 － 0.25 |
Dalbavancin |
1112 |
| Staphylococcus haemolyticus (methicillin-susceptible) |
- |
0.13 |
? － ? |
Dalbavancin |
1112 |
| Staphylococcus haemolyticus (methicillin-susceptible) |
- |
2 |
? － ? |
Vancomycin (Vancocyn, Lyphocin) |
1112 |
| Staphylococcus haemolyticus (methicillin-susceptible) |
- |
8 |
0.015 － 2 |
Ciprofloxacin (Cipro, Ciproxin, Ciprobay) |
12 |
| Staphylococcus haemolyticus (methicillin-susceptible) |
- |
32 |
? － ? |
Teicoplanin (Targocid) |
1112 |
| Staphylococcus haemolyticus (oxacillin-resistant) |
0.25 |
0.25 |
≤0.12 － 0.5 |
Quinupristin/Dalfopristin (Synercid) |
496 |
| Staphylococcus haemolyticus (oxacillin-resistant) |
>0.25 |
>16 |
≤0.25 － >16 |
Clindamycin (Cleocin) |
496 |
| Staphylococcus haemolyticus (oxacillin-resistant) |
>0.5 |
>8 |
0.5 － >8 |
Erythromycin (E-mycin, Ery-tab, Benzamycin) |
496 |
| Staphylococcus haemolyticus (oxacillin-resistant) |
>4 |
>8 |
1 － >8 |
Azithromycin (Zithromax, Sumamed, Zitrocin) |
496 |
| Staphylococcus haemolyticus (oxacillin-susceptible) |
0.06 |
- |
0.06 － >16 |
Telithromycin (HMR 3647, RU-66647, Ketek) |
496 |
| Staphylococcus haemolyticus (oxacillin-susceptible) |
0.25 |
- |
≤0.12 － 0.5 |
Quinupristin/Dalfopristin (Synercid) |
496 |
| Staphylococcus haemolyticus (oxacillin-susceptible) |
0.25 |
- |
0.25 － >8 |
Erythromycin (E-mycin, Ery-tab, Benzamycin) |
496 |
| Staphylococcus haemolyticus (oxacillin-susceptible) |
0.25 |
- |
≤0.25 － >16 |
Clindamycin (Cleocin) |
496 |
| Staphylococcus haemolyticus (oxacillin-susceptible) |
0.5 |
- |
0.5 － >8 |
Azithromycin (Zithromax, Sumamed, Zitrocin) |
496 |
| Staphylococcus haemolyticus (ST065 + coagulase-negative + teicoplanin-resistant) |
- |
- |
0.5 － ? |
Chloroeremomycin (LY264826, A-82846B) |
51 |
| Staphylococcus haemolyticus (ST065 + coagulase-negative + teicoplanin-resistant) |
- |
- |
2 － ? |
LY 191145 |
51 |
| Staphylococcus haemolyticus (ST065 + coagulase-negative + teicoplanin-resistant) |
- |
- |
2 － ? |
Vancomycin (Vancocyn, Lyphocin) |
51 |
| Staphylococcus haemolyticus (ST065 + coagulase-negative + teicoplanin-resistant) |
- |
- |
8 － ? |
Teicoplanin (Targocid) |
51 |
| Staphylococcus haemolyticus (ST105 + coagulase-negative + teicoplanin-resistant) |
- |
- |
2 － ? |
Chloroeremomycin (LY264826, A-82846B) |
51 |
| Staphylococcus haemolyticus (ST105 + coagulase-negative + teicoplanin-resistant) |
- |
- |
4 － ? |
Vancomycin (Vancocyn, Lyphocin) |
51 |